Kaempferol-Mediated Sensitization Enhances Chemotherapeutic Efficacy of Sorafenib Against Hepatocellular Carcinoma: An In Silico and In Vitro Approach

Purpose: Sorafenib is the sole FDA approved drug conventionally used for the treatment of advanced hepatocellular carcinoma (HCC). Despite of the beneficial use of sorafenib in the treatment of HCC, multidrug resistance still remains a challenge. HCC is inherently known as chemotherapy resistant tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Bhagyalakshmi, Anto, Ruby John, M, Sabitha, Nath, Lekshmi R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335979/
https://www.ncbi.nlm.nih.gov/pubmed/32665908
http://dx.doi.org/10.34172/apb.2020.058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335979/
https://www.ncbi.nlm.nih.gov/pubmed/32665908
http://dx.doi.org/10.34172/apb.2020.058

Ejemplares similares